Search results
Delphia starts up with $67M to make a new type of cancer drug
BioPharma Dive via Yahoo Finance· 2 weeks agoThe startup is developing medicines designed to overstress cellular pathways to the point tumor...
Repare Therapeutics Inc (RPTX) Reports Financial Outcomes for Q4 and Full Year 2023
GuruFocus.com via Yahoo Finance· 2 months agoRevenue: Reported a decrease to $13.0 million in Q4 and $51.1 million for the full year, compared to...
Alphabet Inc (GOOGL) Investment Portfolio: Top 15 Companies
Insider Monkey via Yahoo Finance· 1 year agoIn this article, we discuss the top 15 companies in Alphabet Inc (GOOGL)’s investment portfolio. If...
Exelixis (EXEL) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 2 weeks agoImage source: The Motley Fool. Exelixis (NASDAQ: EXEL) Q1 2024 Earnings Call Apr 30, 2024, 5:00 p.m. ET Contents: Prepared Remarks Questions and Answers...
Calithera Biosciences (CALA) Q2 2022 Earnings Call Transcript
Motley Fool· 2 years agoJoining me today are Susan Molineaux, founder, president, and CEO; and Emil Kuriakose, chief medical...
Lantern Pharma Inc. (NASDAQ:LTRN) Q3 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 6 months agoLantern Pharma Inc. (NASDAQ:LTRN) Q3 2023 Earnings Call Transcript November 9, 2023 Operator: Good...
‘The Market Bottom Is Near,’ Says Oppenheimer — Here Are 2 Stocks to Play That Bullish Sentiment
TipRanks via Yahoo Finance· 2 years agoIn a market trending down, there are fewer scenarios more appealing to investors than ones outlining...
IDEAYA Biosciences Inc (IDYA) Reports Q1 2024 Earnings: Financial and Strategic Developments
GuruFocus.com via Yahoo Finance· 6 days agoNet Loss: Reported a net loss of $39.57 million for Q1 2024, slightly below the estimated net loss of $38.88 million. Revenue: No collaboration revenue recognized in Q1 2024, compared to $3.9 ...
